![Richard Mountfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Mountfield
No más puestos en curso
Perfil
Richard Mountfield formerly worked at Celyad Oncology SA, as VP-Global Regulatory Affairs, Constellation Pharmaceuticals, Inc., as Senior Vice President-Regulatory Affairs & Quality from 2020 to 2021, Boston Pharmaceuticals, Inc., as Senior VP-Regulatory Affairs & Drug Development from 2016 to 2020, Zenas BioPharma (USA) LLC, as SVP, Global Head-Regulatory Affairs & Quality from 2021 to 2023, and Aura Biosciences, Inc., as SVP-Regulatory Affairs & Quality.
Dr. Mountfield received his doctorate degree from the University of Aberystwyth and undergraduate degree from Coventry University.
Antiguos cargos conocidos de Richard Mountfield.
| Empresas | Cargo | Fin |
|---|---|---|
| AURA BIOSCIENCES, INC. | Consejero General | 01/12/2025 |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Consejero General | 01/05/2023 |
| CONSTELLATION PHARMACEUTICALS, INC. | Consejero General | 01/10/2021 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Consejero General | 01/07/2020 |
| CELYAD ONCOLOGY SA | Consejero General | - |
Formación de Richard Mountfield.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
23
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Coventry University
 Coventry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
University of Aberystwyth
 University of Aberystwyth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Health Technology |
- Bolsa de valores
- Insiders
- Richard Mountfield
